The MHRA has approved beremagene geperpavec gel for DEB wounds — the first topical gene therapy for the condition, usable from birth.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/uk-approves-first-gene-therapy-gel-rare-skin-disorder-2026a1000g77?src=rss
Author :
Publish date : 2026-05-19 11:50:00
Copyright for syndicated content belongs to the linked Source.